In vitro inhibition of human erythrocyte acetylcholinesterase (EC3.1.1.7) by an antineoplastic drug methotrexate

Molecular and Cellular Biochemistry

Volumn 159, Issue 1, 1996, Pages 47-53

  Kamal, Mohammad A ^a   Nasim, Faizul H ^b   Al Jafari, Abdulaziz A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

Author keywords

Acetylcholinesterase; Anticancer drugs; Human erythrocyte; Inhibition; Kinetics; Methotrexate

Indexed keywords

ACETYLCHOLINESTERASE; ACETYLTHIOCHOLINE; ANTINEOPLASTIC AGENT; METHOTREXATE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; HYDROLYSIS; MALE; MICHAELIS CONSTANT; NORMAL HUMAN; TIME;

EID: 0029941548     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00226062     Document Type: Article

References (15)

1. Bertino JR: Toward improved selectivity in cancer chemotherapy: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 39: 293-304, 1979
2. Avella M, Bacci G, Mcdonald DJ, Discioscio M, Picci P, Campanacci M: Adjuvant chemotherapy with six drugs (adriamycin, methotrexate, cisplatinum, bleomycin, cyclophosphamide and dactinomycin) for non-metastatic, high-grade osteosarcoma ofthe extremities. Chemioterapia 7: 133-137, 1988
3. Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE: Efficacy of low-dose methotrexate in rheumatoid arthritis. New Engl J Med 312: 818-822, 1985
4. Rees RB, Bennt JR, Maibach HI, Arnold HL: Methotrexate for psoriasis. Arch Dermatol 95(1): 2-11, 1967
5. Allen JC, Rosen G: Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma. Ann Neurol 3: 441-444, 1978
6. Haddara MA, El-Badawi MG, Fatani JA., Ibrahim M, Dahaha NM: Neuronal death after I.P. injection of methotrexate in young mice. Al-Azher Med J 14: 25-30, 1985
7. El-Badawi MG, Fatani JA, Qayyum MA: Methotrexate neurotoxicity-a histochemical study. Anat Anz 164: 47-52, 1987
8. Schomagel JH, Me Vie JG: The clinical pharmacology of methotrexate. Cancer Treat Revs 10: 53-75, 1983
9. Dahl MGC, Gregory MM, Schenrer PJ: Liver damage due to methotrexate in patient withpsoriasis. BrMed J1:625-630,1971
10. Leblanc GA, Waxman DJ: Interaction of anticancer drugs with hepatic monooxgenase. Drug Meta Rev 20(2-4): 395-439, 1989
11. Sadzuka Y, Shoji T, Takino Y: Effect of cisplatin on the activites of enzymes which protect against lipid peroxidation. Biochem Pharmacol 43: 1872-1875, 1992
12. Al-Jafari AA: The toxicological effect of cyclophosphamide on acetylcholinesterase activity. Toxicol Lett 66: 125-131, 1993
13. Al-Jafari AA, Duhaiman AS, Kamal MA: Inhibition of human acetylcholinesterase by cyclophosphamide. Toxicology 96 (1): 1-6, 1995
14. Al-Jafari AA, Kamal MA, Duhaiman AS: The mode of inhibition of human erythrocytemembrane bound acetylcholinesterase by cisplatin in vitro. J Enzyme Inhib 8: 281-289, 1995
15. Qayyum MA, Fatalii JA, El-Badawi MG: Partial degeneration of autonomic nerves of the heart of methotrexate-treated guinea pigs. Acta Anat 131: 52-55, 1988